share_log

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

中国制药（纽约证券交易所代码：CPHI）的研究报道从StockNews.com开始
Financial News Live ·  2023/01/19 01:41

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research report released on Monday. The firm issued a hold rating on the stock.

StockNews.com 开始报道的股票 中国制药（纽约证券交易所代码：CPHI-获取评级） 在周一发布的研究报告中。该公司对该股发布了持有评级。

China Pharma Price Performance

中国医药价格表现

Shares of CPHI opened at $0.11 on Monday. China Pharma has a 1-year low of $0.08 and a 1-year high of $0.53. The stock has a market cap of $5.43 million, a PE ratio of -1.31 and a beta of 0.69. The firm has a 50-day simple moving average of $0.11 and a two-hundred day simple moving average of $0.16.

CPHI的股价周一开盘价为0.11美元。中国制药的1年低点为0.08美元，1年高点为0.53美元。该股的市值为543万美元，市盈率为-1.31，beta值为0.69。该公司的50天简单移动平均线为0.11美元，200天的简单移动平均线为0.16美元。

Get
获取
China Pharma
中国制药
alerts:
警报：

About China Pharma

关于中国制药

(Get Rating)

（获取评分）

China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.
China Pharma Holdings, Inc从事药品的开发、制造和营销。该公司的产品组合包括中枢神经系统（CNS）和脑心血管疾病、抗感染和呼吸系统疾病、消化系统疾病、综合医疗保健和保护产品。

Featured Stories

精选故事

  • Get a free copy of the StockNews.com research report on China Pharma (CPHI)
  • Procter & Gamble Earnings: A Gamble Worth Taking
  • Stocks Slide, Economic Report Paints Gloomy Picture For Economy
  • What does Nu Holdings Stock Have To Do With Warren Buffett?
  • J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
  • Is Intel Stock On The Verge Of Breaking Out?
  • 免费获取 StockNews.com 关于中国制药 (CPHI) 的研究报告
  • 宝洁公司收益：一场值得一试的赌博
  • 股市下滑，经济报告描绘了经济的阴暗前景
  • Nu Holdings 的股票与沃伦·巴菲特有什么关系？
  • J.B. Hunt 持平，物流公司成为人们关注的焦点
  • 英特尔股票即将爆发吗？

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

接收《中国医药日报》的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收中国制药及相关公司的最新新闻和分析师评级的简要每日摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发